SCHEMBL6967073

SCHEMBL6967073

COc1ccc(CCc2cc(C)ccc2S(=O)(O)=S)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CALM1 P0DP23 1/20 0.44
LMNA P02545 4/20 0.42
ALOX12 P18054 2/20 0.42
HTT P42858 2/20 0.42
RAB9A P51151 1/20 0.42
ALDH1A1 P00352 4/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MEN1 O00255 1/20 0.40
PKM P14618 1/20 0.40
KMT2A Q03164 1/20 0.40
BCHE P06276 1/20 0.40
ACHE P22303 1/20 0.40
EGFR P00533 1/20 0.40
MAPT P10636 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA5A P35218 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10372347 0.89 CALM1 (0.47) CALM1LMNAALOX12HTTRAB9A
SCHEMBL6963723 0.86 CHRM2 (0.45) ALDH1A1SMN1; SMN2
SCHEMBL6604226 0.83 TDP1 (0.43) LMNAALOX12RAB9AALDH1A1L3MBTL1
SCHEMBL9367114 0.81 IGF1R (0.46) CALM1LMNAHTTALDH1A1MEN1
SCHEMBL5679284 0.80 IDH1 (0.44) LMNAALDH1A1L3MBTL1MEN1PKM
SCHEMBL17710449 0.80 CNR2 (0.45) ALDH1A1L3MBTL1MEN1KMT2AMAPT
SCHEMBL6603746 0.80 IDH1 (0.45) LMNAALDH1A1L3MBTL1ACHESMN1; SMN2
SCHEMBL10592891 0.77 AMY1A (0.35) LMNAHTTALDH1A1L3MBTL1MEN1
SCHEMBL10590939 0.77 AMY1A (0.35) LMNAHTTALDH1A1L3MBTL1MEN1
SCHEMBL7029322 0.77 DAO (0.40) RAB9AALDH1A1L3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed